Literature DB >> 12080219

Familial Crohn's disease in single or multiple first-degree relatives.

Hugh J Freeman1.   

Abstract

The strongest currently recognized risk factor for Crohn's disease (CD) development is having a relative with the disease. In this study, 1,000 patients with CD, seen directly by the investigator during a period of more than 20 years, were consecutively evaluated for a family history of CD. There were 140 patients who reported a relative with CD. Of these, all 87 first-degree relatives were confirmed to have CD (36 men and 51 women). Siblings, particularly women, were most commonly affected in comparison with parents or children. There were 65 with a single affected first-degree relative and 22 with multiple affected first-degree relatives. In this series, the tendency to have a female sibling with CD was further increased in those with multiple affected first-degree relatives. Although the age of diagnosis of children was less than the age of diagnosis in the respective parents, there were almost identical numbers of mother-child and father-child pairs. These findings in a population with prolonged follow-up by the same physician may reflect a bias toward case ascertainment rather than the previously reported phenomena in recruited populations of genetic anticipation and genomic imprinting. Patients with multiple first-degree relatives were older with more extensive disease in both ileal and colonic sites compared with those with only a single first-degree relative and more frequent colonic disease. Future studies are needed to further explore the role of both genetic and environmental factors in the pathogenesis and phenotypic expression of familial CD.

Entities:  

Mesh:

Year:  2002        PMID: 12080219     DOI: 10.1097/00004836-200207000-00004

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  17 in total

Review 1.  Family and twin studies in inflammatory bowel disease.

Authors:  Leena Halme; Paulina Paavola-Sakki; Ulla Turunen; Maarit Lappalainen; Martti Farkkila; Kimmo Kontula
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

2.  Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

3.  Granuloma-positive Crohn's disease.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

4.  Long-term natural history of Crohn's disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

Review 5.  Familial aggregation in inflammatory bowel disease: is it genes or environment?

Authors:  Tiago Nunes; Gionata Fiorino; Silvio Danese; Miquel Sans
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 6.  Natural history and long-term clinical course of Crohn's disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 7.  Influence of environmental factors in the development of inflammatory bowel diseases.

Authors:  Evangelia Legaki; Maria Gazouli
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

8.  Perinatal and early life risk factors for inflammatory bowel disease.

Authors:  Stephen E Roberts; Clare J Wotton; John G Williams; Myfanwy Griffith; Michael J Goldacre
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

9.  Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea.

Authors:  Sook Hee Chung; Soo Jung Park; Hye Sun Lee; Sung Pil Hong; Jae Hee Cheon; Tae Il Kim; Won Ho Kim
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Increased severity over generations of Charcot-Marie-Tooth disease type 1A.

Authors:  I Steiner; M Gotkine; B Steiner-Birmanns; I Biran; S Silverstein; D Abeliovich; Z Argov; I Wirguin
Journal:  J Neurol       Date:  2008-04-30       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.